CME Group Inc. (CME) Downgraded by Zacks to NEUTRAL

Zacks Zacks Investment Research downgraded shares of CME Group Inc. (CME) from OUTPERFORM to NEUTRAL on November 18, 2013, with a target price of $84.00.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on CME Group Inc. (CME),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .

Be the first to comment

Leave a Reply